CARsgen therapeutics announces passing of non-executive director
CARsgen Therapeutics Holdings Limited deeply regrets to announce the peaceful passing of Mr. Bingsen Guo, a non-executive director, on September 24, 2025. Mr. Guo, who served the group for over 10 years, was a core pillar of support, leveraging his business acumen and entrepreneurial experience across strategic transformations, business breakthroughs, and risk mitigation efforts. The board expressed its deepest condolences to his family and gratitude for his valuable contributions.
The current board of directors includes dr. Zonghai Li (chairman), dr. Huamao Wang, and dr. Hua Jiang as executive directors; Mr. Ronggang Xie and the late Mr. Huaqing Guo as non-executive directors; and dr. Guangmei Yan, Ms. Xiangke Zhao, and dr. Wen Zhou as independent non-executive directors.
Prior to his passing, Mr. Guo served as a member of the audit committee.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when CARsgen Therapeutics publishes news
Free account required • Unsubscribe anytime